NEFL and amyotrophic lateral sclerosis: Specifically, in C9orf72 patients, NfL and pNfH were elevated ~3.5 years prior to phenoconversion, highlighting the importance of tracking neurofilament proteins as biomarkers of C9orf72-ALS (Benatar et al., 2019).